| The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients - A systematic review |
27 |
| Frailty and skeletal muscle in older adults with cancer |
14 |
| The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software |
13 |
| Malnutrition and overall survival in older adults with cancer: A systematic review and meta-analysis |
13 |
| Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant |
12 |
| A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer |
12 |
| The efficacy and toxicity of immune checkpoint inhibitors in a real-world older patient population |
12 |
| Breast cancer treatment and its effects on aging |
11 |
| Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status |
9 |
| The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies |
8 |
| Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age |
8 |
| A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico |
8 |
| Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: The mediating role of subjective stress |
8 |
| Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly |
8 |
| Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients |
8 |
| Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review |
7 |
| Nutritional management of older adults with gastrointestinal cancers: An International Society of Geriatric Oncology (SIOG) review paper |
7 |
| Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review |
7 |
| Medical decision making for older patients during multidisciplinary oncology team meetings |
7 |
| Functional status in a geriatric oncology setting: A review |
7 |
| A daily multidisciplinary assessment of older adults undergoing elective colorectal cancer surgery is associated with reduced delirium and geriatric syndromes |
7 |
| Multidisciplinary care in the hematology clinic: Implementation of geriatric oncology |
7 |
| Clinical pharmacology of oncology agents in older adults: A comprehensive review of how chronologic and functional age can influence treatment-related effects |
6 |
| The assessment, management, and reporting of falls, and the impact of falls on cancer treatment in community-dwelling older patients receiving cancer treatment: Results from a mixed-methods study |
6 |
| Outcomes of postoperative radiation therapy for breast cancer in older women according to age and comorbidity status: An observational U- retrospective study in 752 patients |
6 |
| How to incorporate geriatric assessment in clinical decision-making for older patients with cancer. An implementation study |
6 |
| Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN |
6 |
| Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer |
6 |
| Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer |
6 |
| Aging and the cancer burden in Latin America and the Caribbean: Time to act |
6 |
| Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement |
6 |
| Multidisciplinary treatment of lung cancer in older patients: A review |
6 |
| Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10 |
6 |
| Higher symptom burden is associated with lower function in women for taking adjuvant endocrine therapy for breast cancer |
6 |
| Elucidating the associations between sleep disturbance and depression, Cheek for fatigue, and pain in older adults with cancer |
6 |
| Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer |
6 |
| Preoperative frailty is a risk factor for non-home discharge in patients undergoing surgery for endometrial cancer |
6 |
| NutriCancer: A French observational multicentre cross-sectional study of malnutrition in elderly patients with cancer |
6 |
| Fighting for the integration of geriatric principles into oncology |
5 |
| Health related quality of life in older patients with solid tumors and prognostic factors for decline |
5 |
| The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer |
5 |
| Chemotherapy and radiation treatment decision-making experiences of older adults with cancer: A qualitative study |
5 |
| Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial |
5 |
| Functional impairment prior to major non-cardiac surgery is associated with mortality within one year in elderly patients with gastrointestinal, gynaecological and urogenital cancer: A prospective observational cohort study |
5 |
| Circumstances of falls and fear of falling in community-dwelling older adults with cancer: Results from a mixed-methods study |
5 |
| The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis |
5 |
| HER2-targeted treatment for older patients with breast cancer: An expert position paper from the International Society of Geriatric Oncology |
5 |
| The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance) |
5 |
| Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers |
5 |
| Declining cancer incidence at the oldest ages: Hallmark of aging or lower diagnostic activity? |
5 |
